References
- Sahu KK, Prakash G et al. A Rare Case of Haemorrhagic Cystitis
in Allogeneic Haematopoetic Stem Cell Transplant Patient. Indian J of
Haematology and Blood Transfusion 2016; 390: 196-200.
- Ebiloglu T, Kaya E, Yilmaz S, Özgür G, Kibar Y. Treatment of
Resistant Cyclophosphamide Induced Haemorrhagic Cystitis: Review of
Literature and Three Case Reports 2016; 10(4): 15-16.
- Payne H, Adamson A et al. Chemical and Radiation Induced
Haemorrhagic Cystitis: Current Treatments and Challenges. BJU
International 2013; 112(7): 885-897.
- Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk Factors for
Severe Haemorrhagic Cystitis Following BMT. Bone Marrow
Transplantation. 1999. 23: 35-40.
- Decker DB, Karam JA, Wilcox DT. Paediatric Haemorrhagic
Cystitis. Journal of Paediatric Urology 2009; 5: 254-264.
- Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K. Estrogen
as treatment of hemorrhagic cystitis in children and adolescents
undergoing bone marrow transplantation . Bone Marrow Transplant 2006;
37: 523-26.
- Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen
therapy for treatment of haemorrhagic cystitis . J Urol 1994; 151:
1348.17.
- Mukamel E, Lupu A, deKernion JB. Alum irrigation for severe
bladder hemorrhage . J Urol 1986; 135: 784.
- Au JK, Graziano C et al. Urologic Outcomes of Children with
Haemorrhagic Cystitis After Bone Marrow Transplant at a Single
Institution. Urology 2016; 101: 126-132.
- Duthie G, Whyte L, Chandran H, Lawson S, Velangi M, McCarthy L.Introduction of Sodium Pentosan Polysulphate and Avoidance of
Urethral Catheterisation: Improved Outcomes in Children With
Haemorrhagic Cystitis Post Stem Cell Transplant/Chemotherapy. J
Paediatric Surgery 2012; 47(2): 375-9.
- Simerville JA, Maxted WC, Pahira JJ. Urinalysis: A Comprehensive
Review. Am Fam Physician 2005; 71: 1153-1162.
- Hu J, Li S et al. Incidence, Risk Factors and the Effect of
Polyoma Virus Infection in Haematopoetic Stem Cell Transplant
Recipients. J International Medical Research 2017; 45(2): 762-770.
- Lynch JP, Fishbein M, Ecchavaria M. Adenovirus. Seminars in
Respiratory and Critical Care Medicine 2011; 32(4): 494-511.
- Liu H, Chang JY. Proton Therapy in Clinical Practice. Chinese
Journal of Cancer 2011; 30(5): 315-326.
- EMC. Vincristine Sulphate 1mg/ml for Injection. Authorised
2/12/2008. Accessed 10/12/2019 athttps://www.medicines.org.uk/emc/product/1502/smpc.
- EMC. Lomustine “Medac” 40mg. Authorised 25/08/2006. Accessed
10/12/2019 athttps://www.medicines.org.uk/emc/product/1401/smpc.
- Crona DJ, Faso A et al. A Systematic Review of Strategies to
Prevent Cisplatin-Induced Nephrotoxicity. Oncologist 2017; 22(5):
609-619.
- Miller RP, Tadagavadhi RK, Ramesh G, Reeves WB. Mechanisms of
Cisplatin Nephrotoxicity. Toxins 2010; 2(11): 2490-2518.
- Leonhauser D, Kranz J et al. Expression of Components of the
Urothelial Cholinergic System in Bladder and Cultivated Primary
Urothelial Cells of the Pig. BMC Urology 2019; 19: 62.
- Cantwell BM, Harris AL, Patrick D, Hall RR. Haemorrhagic
Cystitis After I.V. Bleomycin, Vinblastine, Cisplatin and Etoposide
for Testicular Cancer. Cancer Treatment Reports 1986; 70(4): 548-9.